Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday. A total of 106 patients with ...

Deep Dive: Research and Development 2025. Every breakthrough in medicine, every new treatment that changes lives, starts with research. R&D Life Sciences Industry Report - Biologics and Generics.